PÅL RYFORS – CEO & ACTING SALES DIRECTOR
Pål has a Bachelor in Financial Economics from Gothenburg School of Economics. He has vast experience from leading positions within the finance and banking sector both in the Nordics and internationally.
Pål has been CFO of Marginalen Bank, a Swedish bank employing some 350 people. Prior to that, he was Head of Group Controlling at Hoist Finance. Before joining Hoist Finance, he was an investment banker at Societe Generale in London, a position he assumed after holding several leading positions in the restructuring of the Swedish operations of Kaupthing Bank.
Other appointments: Board member Aros Kapital AB, Aros Kapital Ltd and Doxa AB
No of B shares: 2,042,757
No of employee stock options: 170,950
No of performance options: 756,942
No of warrants: 25,000
No of warrants TO4B 24,681
VERONICA WALLIN – CFO
Veronica has a Degree of Master of Science in Business and Economics from Stockholms University and was employed by Episurf Medical in August 2016 as Head of Finance. In June 2017 Veronica became CFO after Pål Ryfors, who then resigned as CFO.
Prior to joining Episurf Medical Veronica worked as Head of Finance at ApoEx during 2013-2016.
No of B shares: 36,500
No of employee stock options: 182,350
No of performance options: 358,282
No of warrants: 34,600
No of warrants TO4B: 148
KATARINA FLODSTRÖM – COO
Katarina has a PhD in Physical Chemistry from Lund University and a MSc in Chemical Engineering from the Royal Institute of Technology in Stockholm. She was employed by Episurf Medical in 2014. Katarina has more than 15 years’ experience from RnD in start-up companies. She was the RnD Manager and Quality Manager of Diamorph AB from which Episurf is a spin-off.
No of B shares: 103,125 (of which 28,875 is family members)
No of employee stock options: 182,400
No of performance options: 365,448
No of warrants: 21,200
No of warrants TO4B: 555 (of which 259 is family members)
FREDRIK ZETTERBERG – MARKETING DIRECTOR
Fredrik was employed by Episurf Medical AB in February 2016 and has 20 years of experience from medical technology companies such as Baxter, Cardinal Health, ArthroCare and Smith & Nephew.
Since 2008 the focus has been on orthopedics where he has held senior positions within sales management and international marketing.
No of B shares: 26,500
No of employee stock options: 173,450
No of performance options: 378,202
No of warrants: 22,700
No of warrants TO4B: 148
MICHAEL NÄSSTRÖM – HEAD OF QUALITY & REGULATORY AFFAIRS
Michael has a Master of Science in Medical Engineering from the Royal Institute of Technology in Stockholm and was employed by Episurf Medical in October 2018.
Previously Michael has been working as a consultant within the life science and medical device industry, of which one year was spent at Episurf Medical.
No of B shares: 4,000
No of employee stock options: 140,000
No of performance options: 66,814
No of warrants: 10,000